Literature DB >> 24382715

Regularized rare variant enrichment analysis for case-control exome sequencing data.

Nicholas B Larson1, Daniel J Schaid.   

Abstract

Rare variants have recently garnered an immense amount of attention in genetic association analysis. However, unlike methods traditionally used for single marker analysis in GWAS, rare variant analysis often requires some method of aggregation, since single marker approaches are poorly powered for typical sequencing study sample sizes. Advancements in sequencing technologies have rendered next-generation sequencing platforms a realistic alternative to traditional genotyping arrays. Exome sequencing in particular not only provides base-level resolution of genetic coding regions, but also a natural paradigm for aggregation via genes and exons. Here, we propose the use of penalized regression in combination with variant aggregation measures to identify rare variant enrichment in exome sequencing data. In contrast to marginal gene-level testing, we simultaneously evaluate the effects of rare variants in multiple genes, focusing on gene-based least absolute shrinkage and selection operator (LASSO) and exon-based sparse group LASSO models. By using gene membership as a grouping variable, the sparse group LASSO can be used as a gene-centric analysis of rare variants while also providing a penalized approach toward identifying specific regions of interest. We apply extensive simulations to evaluate the performance of these approaches with respect to specificity and sensitivity, comparing these results to multiple competing marginal testing methods. Finally, we discuss our findings and outline future research.
© 2013 WILEY PERIODICALS, INC.

Entities:  

Keywords:  LASSO; association analysis; exome sequencing; rare variants; regularization

Mesh:

Year:  2013        PMID: 24382715      PMCID: PMC3985431          DOI: 10.1002/gepi.21783

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  45 in total

Review 1.  Protein domains correlate strongly with exons in multiple eukaryotic genomes--evidence of exon shuffling?

Authors:  Mingyi Liu; Andrei Grigoriev
Journal:  Trends Genet       Date:  2004-09       Impact factor: 11.639

2.  Potential etiologic and functional implications of genome-wide association loci for human diseases and traits.

Authors:  Lucia A Hindorff; Praveen Sethupathy; Heather A Junkins; Erin M Ramos; Jayashri P Mehta; Francis S Collins; Teri A Manolio
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-27       Impact factor: 11.205

3.  Empirical power of very rare variants for common traits and disease: results from sanger sequencing 1998 individuals.

Authors:  Martin Ladouceur; Hou-Feng Zheng; Celia M T Greenwood; J Brent Richards
Journal:  Eur J Hum Genet       Date:  2013-01-16       Impact factor: 4.246

4.  Multilocus association testing with penalized regression.

Authors:  Saonli Basu; Wei Pan; Xiaotong Shen; William S Oetting
Journal:  Genet Epidemiol       Date:  2011-09-15       Impact factor: 2.135

5.  Genes-in-pieces revisited.

Authors:  W Gilbert
Journal:  Science       Date:  1985-05-17       Impact factor: 47.728

6.  Penalized logistic regression for high-dimensional DNA methylation data with case-control studies.

Authors:  Hokeun Sun; Shuang Wang
Journal:  Bioinformatics       Date:  2012-03-30       Impact factor: 6.937

7.  A strategy to discover genes that carry multi-allelic or mono-allelic risk for common diseases: a cohort allelic sums test (CAST).

Authors:  Stephan Morgenthaler; William G Thilly
Journal:  Mutat Res       Date:  2006-11-13       Impact factor: 2.433

8.  Regularization Paths for Generalized Linear Models via Coordinate Descent.

Authors:  Jerome Friedman; Trevor Hastie; Rob Tibshirani
Journal:  J Stat Softw       Date:  2010       Impact factor: 6.440

9.  Link functions in multi-locus genetic models: implications for testing, prediction, and interpretation.

Authors:  David Clayton
Journal:  Genet Epidemiol       Date:  2012-04-16       Impact factor: 2.135

10.  Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease.

Authors:  Manuel A Rivas; Mélissa Beaudoin; Agnes Gardet; Christine Stevens; Yashoda Sharma; Clarence K Zhang; Gabrielle Boucher; Stephan Ripke; David Ellinghaus; Noel Burtt; Tim Fennell; Andrew Kirby; Anna Latiano; Philippe Goyette; Todd Green; Jonas Halfvarson; Talin Haritunians; Joshua M Korn; Finny Kuruvilla; Caroline Lagacé; Benjamin Neale; Ken Sin Lo; Phil Schumm; Leif Törkvist; Marla C Dubinsky; Steven R Brant; Mark S Silverberg; Richard H Duerr; David Altshuler; Stacey Gabriel; Guillaume Lettre; Andre Franke; Mauro D'Amato; Dermot P B McGovern; Judy H Cho; John D Rioux; Ramnik J Xavier; Mark J Daly
Journal:  Nat Genet       Date:  2011-10-09       Impact factor: 38.330

View more
  5 in total

Review 1.  Case-only exome sequencing and complex disease susceptibility gene discovery: study design considerations.

Authors:  Lang Wu; Daniel J Schaid; Hugues Sicotte; Eric D Wieben; Hu Li; Gloria M Petersen
Journal:  J Med Genet       Date:  2014-11-04       Impact factor: 6.318

2.  Fine-mapping additive and dominant SNP effects using group-LASSO and fractional resample model averaging.

Authors:  Jeremy Sabourin; Andrew B Nobel; William Valdar
Journal:  Genet Epidemiol       Date:  2014-11-21       Impact factor: 2.135

3.  EPS-LASSO: test for high-dimensional regression under extreme phenotype sampling of continuous traits.

Authors:  Chao Xu; Jian Fang; Hui Shen; Yu-Ping Wang; Hong-Wen Deng
Journal:  Bioinformatics       Date:  2018-06-15       Impact factor: 6.937

4.  Assessing the Power of Exome Chips.

Authors:  Christian Magnus Page; Sergio E Baranzini; Bjørn-Helge Mevik; Steffan Daniel Bos; Hanne F Harbo; Bettina Kulle Andreassen
Journal:  PLoS One       Date:  2015-10-05       Impact factor: 3.240

5.  Beyond Rare-Variant Association Testing: Pinpointing Rare Causal Variants in Case-Control Sequencing Study.

Authors:  Wan-Yu Lin
Journal:  Sci Rep       Date:  2016-02-23       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.